Photo, L-R: Ramon E. Parsons, MD, PhD and Cardinale B. Smith, MD, PhD, Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai
CONFRONTING CANCER: WHAT ADVANCES ARE BEING MADE IN RESEARCH AND CARE?
FREE ONLINE TALK WITH MOUNT SINAI EXPERTS WEDNESDAY, JANUARY 18, 7PM ET, MODERATED BY USA TODAY’S HEALTH REPORTER KAREN WEINTRAUB
Cancer is a wily, ever-changing disease challenging researchers and clinicians to find ways to improve treatments and enhance care. Join leaders from the Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai to discover what new potential cures are on the horizon, how clinicians are partnering with patients to assist in coping and conquering their illness, and why it’s important to include diverse populations in the development of treatments. Register here for the free online talk Wed, Jan 18, 7 pm ET, with experts Ramon E. Parsons, MD, PhD and Cardinale B. Smith, MD, PhD, moderated by USA Today’s Health Reporter, Karen Weintraub.
About Ramon E. Parsons, MD, PhD
Ramon E. Parsons, MD, PhD, is an Icahn Scholar, Director of The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai and Ward-Coleman Chair in Cancer Research. He is also Director, Mount Sinai Tisch Cancer Center, Mount Sinai Health System, and Professor and Chair of the Department of Oncological Sciences at the Icahn School of Medicine.
In 2017, Dr. Parsons was named Director of The Tisch Cancer Institute and Director of Mount Sinai Cancer after serving as the co-Leader of the Cancer Mechanisms program and the Deputy Director of TCI. Dr. Parsons joined the Icahn School of Medicine in 2013.
Previously, he was on the faculty of the departments of Pathology and Medicine at Columbia University Medical Center. He was appointed Assistant Professor in 1995 and later became the Avon Foundation Chair for Breast Cancer Research in 2002. He was promoted to Professor in 2007 and Leader of its Breast Cancer Program at the Herbert Irving Comprehensive Cancer Center in 2005. Dr. Parsons is a member of the National Academy of Medicine, American Society for Clinical Investigation, and American College of Physicians. He was Chair of the AACR Special conferences committee for two terms from 2011-2017, which initiated and planned more than 75 scientific meetings on different cancer-related topics.
Dr. Parsons maintains an active laboratory and has received multiple awards for his research, including the 2011 American Association for Cancer Research (AACR) Outstanding Investigator Award for Breast Cancer Research and a 2017 National Cancer Institute Outstanding Investigator Award. He is internationally recognized as an expert in the fields of cancer genetics and signal transduction with an emphasis on the tumor suppressor gene PTEN.
About Cardinale B. Smith, MD, PhD
Cardinale B. Smith, MD, PhD is a professor with tenure in the Division of Hematology and Medical Oncology and the Brookdale Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai and the Chief Quality Officer for Cancer Services, Mount Sinai Health System. She is a medical oncologist and palliative care physician whose clinical practice is focused on lung cancer and palliative care. Her research interests focus on doctor-patient communication, evaluating treatment disparities in cancer care, determinants of cancer patients’ quality of care, characterizing barriers to optimal cancer and palliative care and developing approaches to eliminating those barriers among racial and ethnic minorities. Dr. Smith is a 2013 recipient of a mentored research scholar grant from the American Cancer Society to evaluate determinants of disparities in the utilization of palliative care among patients with lung cancer. She was a co-investigator on a Patient Centered Outcomes Research Institute grant to teach and enable goals of care conversations among oncologists. Additionally, she is the recipient of Sojourn’s Scholar Leadership Grant and an R01 grant, extremely competitive federal funding, from the National Cancer Institute to evaluate the role of implicit bias among oncologists on minority cancer patient outcomes. Dr. Smith has had numerous publications in peer-reviewed journals, and in 2015 was named one of the Top 40 Inspirational Leaders under 40 by the American Academy of Hospice and Palliative Medicine.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report’s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools,” aligned with a U.S. News & World Report “Honor Roll” Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York City and in the top five globally, and Mount Sinai Morningside in the top 30 globally; Newsweek also ranks The Mount Sinai Hospital highly in 11 specialties in “World’s Best Specialized Hospitals,” and in “America’s Best Physical Rehabilitation Centers.” For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter, and YouTube.
About The 92nd Street Y, New York
The 92nd Street Y, New York (92NY) is a world-class center for the arts and innovation, a convener of ideas, and an incubator for creativity. 92NY offers extensive classes, courses and events online including live concerts, talks and master classes; fitness classes for all ages; 250+ art classes, and parenting workshops for new moms and dads. The 92nd Street Y, New York is transforming the way people share ideas and translate them into action all over the world. All of 92NY’s programming is built on a foundation of Jewish values, including the capacity of civil dialogue to change minds; the potential of education and the arts to change lives; and a commitment to welcoming and serving people of all ages, races, religions, and ethnicities. For more information, visit www.92NY.org.
This program is part of 92NY Recanati-Kaplan Talks.